Skip to main content

X4 Pharmaceuticals, Inc

XFOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001501697

In the last 90 days, X4 Pharmaceuticals, Inc insiders filed 0 open-market purchases and 2 sales; 89 institutions reported holding it in 13F filings for Q2 2026, worth $463.0M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding X4 Pharmaceuticals, Inc changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of XFOR: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders9899+1
Shares103.0M101.5M−1.46M (−1.4%)
Value$143.2M$58.9M−$84.2M (−58.8%)

New holders (18)

Institutions that held X4 Pharmaceuticals, Inc at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to XFOR in Q2 2024
InstitutionSharesValue% of portfolio
Velan Capital Investment Management LP659,020$382.2K0.22%
K2 Principal Fund, L.P.489,158$283.7K0.06%
Diametric Capital, LP448,594$260.2K0.14%
Hudson Bay Capital Management LP227,246$131.8K0.00%
Prelude Capital Management, LLC163,367$94.8K0.01%
XTX Topco Ltd111,245$64.5K0.01%
Corebridge Financial, Inc.90,404$52.4K0.00%
Simplex Trading, LLC75,405$43.0K0.00%
Mirae Asset Global ETFs Holdings Ltd.63,453$36.8K0.00%
Virtu Financial LLC50,537$29.0K0.00%
Allred Capital Management, LLC12,800$7.42K0.00%
Jump Financial, LLC10,362$6.01K0.00%
Russell Investments Group, Ltd.1,901$1.10K0.00%
SRS Capital Advisors, Inc.503$2920.00%
Advisor Group Holdings, Inc.400$2320.00%
HighMark Wealth Management LLC180$1040.00%
Nisa Investment Advisors, LLC49$280.00%
Headlands Technologies LLC16$90.00%

Sold out (17)

Institutions that held X4 Pharmaceuticals, Inc at the end of Q1 2024 and filed for Q2 2024 without it.